MM is neutral to positive the ASX200 Pharmaceuticals, Biotech & Life Sciences Index

22/03/2022

MM is neutral to positive the ASX200 Pharmaceuticals, Biotech & Life Sciences Index

Subscribe to Market Matters Blog

Latest Reports

Afternoon report 01/07/2026

The Match Out: Banks stumble as the new financial year begins

The ASX kicked off FY27 with a disappointing start, with heavy selling across the banks and consumer staples proving too much to overcome despite a solid rebound in the resources sector. The market drifted lower through the session as investors locked in profits from some of FY26's biggest winners, while strength in Materials and Healthcare provided little support against broad-based weakness elsewhere.

Morning report 01/07/2026

Portfolio Positioning: Will the Resources Outperform Again in FY27

The ASX200 accelerated on the downside into the EOFY close on Tuesday, ultimately finishing the session down by -0.5% with investors appearing keen to lock in some tax losses ahead of FY27. The market ultimately waved goodbye to FY26 with a paltry +2.8% gain, although considering we had a war in the middle of it and oil trading above US100/barrel it wasn’t a bad result. We expect FY27 to deliver similar volatility on the stock and sector level but hopefully without the geopolitical interruptions.